 Scientists at the J. Craig Venter institute were able to synthesize an artificial bacterium called JCVI-syn1.0 in May of 2010. While media paid attention to this breakthrough, they tended to focus on the potential ethical and social impacts of the creation of artificial bacteria. Craig Venter himself launched a public relations campaign trying to steer the conversation about issues relating to creating life. This first episode in the synthesis of life gives us a taste of the excitement and controversy that will be generated when more viable and robust artificial protocells are synthesized. The ethical concerns raised by Wet ALife, as this kind of research is called, are more properly the jurisdiction of bioethics (see entry on  theory and bioethics).  But it does have some concern for us here in that Wet ALife is part of the process of turning theories from the life sciences into information technologies. This will tend to blur the boundaries between bioethics and information ethics. Just as software ALife might lead to dangerous malware, so too might Wet ALife lead to dangerous bacteria or other disease agents. Critics suggest that there are strong moral arguments against pursuing this technology and that we should apply the precautionary principle here which states that if there is any chance at a technology causing catastrophic harm, and there is no scientific consensus suggesting that the harm will not occur, then those who wish to develop that technology or pursue that research must prove it to be harmless first (see Epstein 1980). Mark Bedau and Mark Traint argue against a too strong adherence to the precautionary principle by suggesting that instead we should opt for moral courage in pursuing such an important step in human understanding of life (2009). They appeal to the Aristotelian notion of courage, not a headlong and foolhardy rush into the unknown, but a resolute and careful step forward into the possibilities offered by this research.